Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brito

Showing results (441-450 of 454) with videos related to

Pageof 46
Sort By:
Neurobiology of Disease|October 27, 2024
Corrigendum to "TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43" [Neurobiology of disease Volume 193, April 2024, 106437]Juan M Godoy-Corchuelo, Zeinab Ali, Jose M Brito Armas, et al.
Neurobiology of Disease|February 17, 2024
TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43Juan M Godoy-Corchuelo, Zeinab Ali, Jose M Brito Armas, et al.
Iscience|January 6, 2022
Generation and analysis of innovative genomically humanized knockin <i>SOD1</i>, <i>TARDBP</i> (TDP-43), and <i>FUS</i> mouse modelsAnny Devoy, Georgia Price, Francesca De Giorgio, et al.
Infection|February 29, 2012
Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)V D Rosenthal, B Ramachandran, W Villamil-Gómez, et al.
Iscience|March 17, 2022
Erratum: Generation and analysis of innovative genomically humanized knockin <i>SOD1</i>, <i>TARDBP</i> (TDP-43), and <i>FUS</i> mouse modelsAnny Devoy, Georgia Price, Francesca De Giorgio, et al.
The New England Journal of Medicine|January 17, 2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax MalariaAlejandro Llanos-Cuentas, Marcus V G Lacerda, Tran T Hien, et al.
Nature Communications|June 4, 2020
Plasma-derived extracellular vesicles from Plasmodium vivax patients signal spleen fibroblasts via NF-kB facilitating parasite cytoadherenceHaruka Toda, Miriam Diaz-Varela, Joan Segui-Barber, et al.
Plos Neglected Tropical Diseases|May 18, 2021
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study)Jose Diego Brito-Sousa, Felipe Murta, Sheila Vitor-Silva, et al.
The EMBO Journal|May 17, 2018
Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosisPietro Fratta, Prasanth Sivakumar, Jack Humphrey, et al.
The New England Journal of Medicine|January 17, 2019
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax MalariaMarcus V G Lacerda, Alejandro Llanos-Cuentas, Srivicha Krudsood, et al.
Pageof 46

Showing results (441-450 of 454) with videos related to

Sort By:
Pageof 46
Neurobiology of Disease|October 27, 2024
Corrigendum to "TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43" [Neurobiology of disease Volume 193, April 2024, 106437]Juan M Godoy-Corchuelo, Zeinab Ali, Jose M Brito Armas, et al.
Neurobiology of Disease|February 17, 2024
TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43Juan M Godoy-Corchuelo, Zeinab Ali, Jose M Brito Armas, et al.
Iscience|January 6, 2022
Generation and analysis of innovative genomically humanized knockin <i>SOD1</i>, <i>TARDBP</i> (TDP-43), and <i>FUS</i> mouse modelsAnny Devoy, Georgia Price, Francesca De Giorgio, et al.
Infection|February 29, 2012
Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)V D Rosenthal, B Ramachandran, W Villamil-Gómez, et al.
Iscience|March 17, 2022
Erratum: Generation and analysis of innovative genomically humanized knockin <i>SOD1</i>, <i>TARDBP</i> (TDP-43), and <i>FUS</i> mouse modelsAnny Devoy, Georgia Price, Francesca De Giorgio, et al.
The New England Journal of Medicine|January 17, 2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax MalariaAlejandro Llanos-Cuentas, Marcus V G Lacerda, Tran T Hien, et al.
Nature Communications|June 4, 2020
Plasma-derived extracellular vesicles from Plasmodium vivax patients signal spleen fibroblasts via NF-kB facilitating parasite cytoadherenceHaruka Toda, Miriam Diaz-Varela, Joan Segui-Barber, et al.
Plos Neglected Tropical Diseases|May 18, 2021
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study)Jose Diego Brito-Sousa, Felipe Murta, Sheila Vitor-Silva, et al.
The EMBO Journal|May 17, 2018
Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosisPietro Fratta, Prasanth Sivakumar, Jack Humphrey, et al.
The New England Journal of Medicine|January 17, 2019
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax MalariaMarcus V G Lacerda, Alejandro Llanos-Cuentas, Srivicha Krudsood, et al.
Pageof 46